GET A PIECE OF PURACLENZ
Revolutionary, Low Cost, and Patented Products - Our scientifically proven technology automatically destroys dangerous pathogens mid-air and on surfaces at the source
Massive, Flourishing Market - Puraclenz already has thousands of installations in the $11.6 billion air purification market projected to grow at a 10% CAGR
Experienced and Passionate Team - Previously generated millions in revenue and developed over 20 patent-to-market products
Puraclenz Holdings, Inc. is the parent corporation of Puraclenz LLC, which is a wholly-owned subsidiary. Puraclenz LLC is the operating entity that was formed on June 25, 2020. The Company later formed Puraclenz Holdings, Inc. on December 29, 2021. All investors in this Reg CF offering will become shareholders of Puraclenz Holdings, Inc., which will be the sole member of Puraclenz LLC. The funds raised from this Reg CF offering and received by Puraclenz Holdings, Inc. will flow to Puraclenz LLC on an as-needed basis.
We’re not just another air purifier. Standard air cleaners only trap pathogens that pass through their filter… But us? We clean indoor air and surfaces at the source – destroying viruses, mold and bacteria - what we believe is the premier practice to clean air in today’s world.
With a Puraclenz device, you’re treated like one of NASA’s esteemed astronauts. We use an evolved form of the same technology (photocatalytic oxidation) used to provide clean air to astronauts on the International Space Station. Our products clean the air you breathe using IP-protected innovations.
The last two years of the ongoing global health crisis have created a new need. People are seeking a cost-effective and automatic solution to destroy pathogens mid-air and on surfaces.
It’s not enough to wear masks and wipe down surfaces anymore. Consumers need a product that raises the bar in technology, design, and price.
We’re currently selling five P-Series SKUs throughout North America, with distribution expanding to Europe, India, Southeast Asia, and Japan. In 2022, Puraclenz plans to introduce four new C-Series SKUs that combine our patented Next-Gen PCO technology with True HEPA. The result? What we believe is the most complete air purifier in the market.
Model P1500 shown
We live in a world where pathogens dangerously disrupt every aspect of life. COVID-19 did and (continues to do) more damage than just getting people sick. Businesses closed. Graduations were canceled. Celebrations ruined. In the U.S. alone, there have been over 60 million Covid cases and over 829,000 Covid related deaths.
All types of pathogens, like viruses, bacteria, and mold, can cause major worldwide health issues. They are responsible for serious illnesses and infections, and even allergic reactions. Every year, 2.8 million bacterial infections occur in the U.S., and more than 35,000 people die. Up to 11% of people in the U.S. get the influenza flu annually. Even 93% of chronic sinus infections are attributed to mold. Excessive concentrations of bacteria, viruses, and molds can trigger asthma episodes for 15 million Americans.
Standard air purifiers clearly aren’t effective enough at destroying these pathogens. HEPA, a standard device, only collects particles that pass through its filter. Then, it uses air changes to clean pathogens in the room.
These air changes take time. Ten to sixty minutes to be exact. By the time the cleaning is finished, people in the space could have already inhaled the pathogens.
Puraclenz is addressing the fast-growing $11.6 billion air purification market. It’s estimated to accelerate to $22.8 billion over the next six years, with a 10% CAGR.
Source: Grand View Research
Industry analysts created those market estimates before COVID-19 started. We can only imagine the elevated market potential since the virus took off and developed its growing number of dangerous variants.
Several companies and technologies compete with us in the Interior Air Quality (IAQ) sector. This sector uses various technologies, including UV light-based systems, hydrogen peroxide, negative ionizers, and more.
Most competitors’ products are considered “passive” devices, which have serious drawbacks:
Only treat air that passes through their device
Regularly require expensive filters changes
Do not clean surfaces
There is a large price range for air purification. UV robots can cost $125,000 and small HEPA products cost $99.99. Our tech exceeds both competing capabilities at a price range between $299 and $499.
Our proprietary technology offers a unique market opportunity for powerful, low-cost, and certified safe air. We believe Puraclenz is the lowest cost professional-grade system.
The company’s patent portfolio protects the advanced PCO design. We have four issued patents and six other pending patents. Plus our mass production process uses trade secrets that allow our purifiers to produce an extraordinarily high density of ions providing an unprecedented competitive advantage in the marketplace.
Complete air purification through small, inexpensive devices
Puraclenz provides continuous cleaning coverage in large areas with low energy consumption. And it’s easy too. Just plug in the unit, run continuously, and breathe easy knowing any pathogens are being destroyed at the source.
We believe Puraclenz is the next generation of indoor air purification. Our devices use internal UV light that reflects onto a patented titanium catalyst, generating an extraordinarily high density of positive and negatively charged ions. These ions are the heroes–– they cling to and deactivate the pathogens mid-air and on exposed surfaces.
We now sell three purifier models that clean 750, 1,500, or 3,000 square feet areas. Since Puraclenz generates no fumes or harmful chemicals and is certified ozone-free, it’s safe to use around children and pets. Our lab studies also show, when Puraclenz is used in a room, it overwhelmingly halts the growth of mold.
Puraclenz develops, manufactures, and markets its proprietary air purification products to businesses and consumers worldwide. In the U.S., we manage all marketing, sales, and customer support activities directly. We currently sell through three distribution channels.
PCO technology has been safely purifying the air and exposed surfaces for over 40 years. We advanced the power and safety of this technology with our patented cell design. Puraclenz’s design generates an extraordinarily high density of pathogen-destroying ions without producing any harmful by-products. Hand-cleaning or HEPA filters don’t cut it. Our design kills the pollutants they miss.
Our numbers speak for themselves. Since we launched in May 2021, Puraclenz has already generated over $700,000 in revenue with thousands of installations. Many universities, luxury hotels, schools, fitness centers, grocery stores, and small businesses nationwide are using Puraclenz to clean their air and surfaces.
*Revenue of the company's subsidiary, Puraclenz, LLC.
We currently sell five SKUs through four distribution channels in the U.S., Canada, and Mexico. In the U.S., Puraclenz sells air purification equipment direct to home, business customers from Puraclenz.com, and in bulk through its team of sales reps and network of distributors. We have master distributor agreements for Canada and Mexico.
Puraclenz has an aggressive five-year growth plan to address this accelerating market. We hope to see annual revenues of $200 million at the end.
In 2022, Puraclenz plans to introduce four more SKUs and expand worldwide distribution to Europe, Japan, India, Southeast Asia, and the Middle East.
We project that U.S. distribution will also expand in the next two years. In 2022, Puraclenz hopes to expand distribution to online marketplaces like Amazon, Walmart.com, Rakuten, and Houzz. In 2023 and 2024, we aim that our products will be sold in home retail stores, such as Best Buy, Target, Bed Bath Beyond, Home Depot, Lowes, and more.
Global concerns of viral spread are growing. Every business and household needs better air purification. Our devices are scientifically proven to proactively reduce viruses mid-air and on exposed surfaces.
We believe Puraclenz’s geographic, application, and technology segmentation offers a large growth potential in the air purification market. Our products are backed by a strong and experienced management team and protected by a global patent portfolio.
This is your chance to participate in a market opportunity with disruptive technology. We’ve created a low-cost product that efficiently addresses what we feel is the biggest global health crisis in over 100 years. It feels good knowing we’re making a difference.
We’re so proud of our success with Puraclenz in just one year. Your investment will push us closer to our ambitious expansion goals in the years to come. Let’s protect people from pathogens and help them breathe easily. Join us!
Goodbye, viruses and mold. Hello to the future of clean. Puraclenz cleans indoor air and exposed surfaces in homes and businesses at the source. Our revolutionary, certified ozone-free PCO technology continuously deactivates dangerous pathogens, including mold spores, viruses, bacteria, fungal allergens, and odors. We’re a revenue-generating, air purification manufacturer and marketing company addressing the $11.6 billion interior air purification market.
Chris is an accomplished senior executive, entrepreneur, and consultant with more than 25 years of success in SMART consumer product industries. He has held leadership positions with Marvel's toy division, Product Spring, Online Devices and iRobot. Chris led operations, U.S. sales, and marketing for iRobot’s Roomba launch and later established Roomba’s international distribution network in Europe, Canada, Russia, Korea, Japan, and Greater China. Chris is successful serial entrepreneur who has founded 5 startups, invented over 80 consumer products and 15 issued patents.
Chris has a Bachelor of Science in Mechanical Engineering from Villanova University and an MBA from New York University.
Wendell has an extensive career as a founder, investor, and manager of early-stage companies in the energy/energy tech, materials science/nanotech, software systems, and direct consumer products industries. He has developed and commercialized advanced ceramic and nano-composite material technologies for military and commercial applications, raising more than $500 million in equity investments. His pre-seed investment in UVAIRx, Inc., enabled the advancement of photocatalytic oxidation (PCO) technology and the securing of a U.S. patent.
Wendell received a bachelor’s degree in Business from Principia College and completed MBA studies in International Economics at New York University and the London School of Economics.
Vice President of R&D
Jerrod spent 10 years as the head of research and development for UVAIRx, Inc., where he was responsible for designing and developing all UVAIRx air purification products. He oversaw UVAIRx products from initial concept design and 3D modeling, to rapid prototyping and patent protection, to design for manufacture and assembly, to product testing. He is the inventor of Puraclenz's reaction core system for the photocatalytic purifiers patent.
Jerrod earned his bachelor’s degree in Environmental Design (Architecture) from the University of Colorado Boulder.
Consultant - Vice President of Marketing Strategy
Myorr served as the Chief Marketing Officer of Rush Communications and Simmons Design Group. He was responsible for Global Marketing, Corporate Communications and Business Development initiatives. With over 25 years of marketing experience, Myorr successfully managed a variety of brands spanning diverse sectors in entertainment, lifestyle, and philanthropy including: Def Jam Recordings, Def Comedy Jam, Phat Farm, Rush Philanthropic Arts Foundation, Hip Hop Summit Action Network, Def Jam Interactive, Simmons Lathan Media Group and more.
Myorr has a Bachelor of Business Management from St. Paul’s College.
Consultant - Vice President of Digital Marketing
Ben started his career at top-tier web companies such as eBay and Overstock.com, where he directed user acquisition marketing campaigns. Ben later consulted for companies specializing in media, fintech (financial services) and e-commerce, ranging from pre-series A start-ups to public companies.
Ben graduated from the David Eccles School of Business at the University of Utah with a Bachelor of Finance.
Cynthia comes to Puraclenz from the commercial real estate sector where she worked in cash management and finance.
Cynthia received her BA in International Relations and Economics from Goucher College and completed her MA in International Affairs at The University of Chicago.
Richard Mangi MD, MBA
Chief Medical Advisor
Richard's practice expertise includes the treatment of allergies, asthma, sinus disease, muscle and joint problems, complicated infections and travel medicine. For over twenty years Richard was Chief of Allergy, Rheumatology and Infectious Disease at the Hospital of Saint Raphael. He has also maintained a private practice in the greater New Haven area since 1974. He is a retired clinical associate professor of medicine at Yale Medical School.
Richard graduated from Cornell University College of Arts and Science and S.U.N.Y. Downstate Medical Center summa cum laude. His post graduate medical training included internship and residency in internal medicine at Yale-New Haven Hospital, staff associate at the National Institutes of Health, National Cancer Institute, and fellowship at Yale Medical School. He also received an M.B.A. with honors from New York University Stern School of Business.
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Friends and Family: Invest within the first 72 hours and receive 15% bonus shares.
Super Early Bird: Invest within the first week and receive 10% bonus shares.
Early Bird Bonus: Invest within the first 2 weeks and receive 5% bonus shares.
Invest $500+: Receive 30% off first purchase (up to $150 retail value)
Invest $1,000+: Receive 1 FREE P750 Purifier ($299 retail value)
Invest $5,000+: Receive 5% bonus shares + Receive 2 FREE Purifiers of your choice (up to $999 retail value)
Invest $10,000+: Receive 7% bonus shares + Receive 3 FREE Purifiers of your choice (up to $1,499 retail value)
Invest $25,000+: Receive 10% bonus shares + Receive 4 FREE Purifiers of your choice (up to $1,999 retail value)
Invest $50,000+: Receive 15% bonus shares + Receive 6 FREE Purifiers of your choice (up to $2,999 retail value)
Invest $100,000+: Receive 20% bonus shares + Receive 8 FREE Purifiers of your choice (up to $4,999 retail value)
*All perks occur when offering is complete.
Puraclenz Holdings, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class B Non-Voting Common Stock at $8.00 / share, you will receive 10 additional shares of Class B Non-Voting Common Stock, meaning you'll own 110 shares for $800. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Officers, directors, executives, and existing owners with a controlling stake in the company (or their immediate family members) may make investments in this offering. Any such investments will be included in the raised amount reflected on the campaign page.
Irregular Use of Proceeds
Example - The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments and salary made to one's self, a friend or relative; Any expense labeled "Administration Expenses" that is not strictly for administrative purposes; Any expense labeled "Travel and Entertainment"; Any expense that is for the purposes of inter-company debt or back payments.
PINNED BY STARTUP
2 years ago
a year ago
a year ago
a year ago
a year ago
a year ago
a year ago
a year ago
a year ago
2 years ago
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.